TOWERVIEW LLC CRVS Holdings History
TOWERVIEW LLC's Corvus Pharmaceuticals Inc Holding Summary
As of 2025-03-31, TOWERVIEW LLC held 127,500.00 shares of Corvus Pharmaceuticals Inc(CRVS), totaling $405,450.00. This investment constitutes 0.29% of their stock portfolio, and TOWERVIEW LLC now holds 0.19% of the outstanding Corvus Pharmaceuticals Inc(CRVS) stock.
The initial trade took place in 2023Q2. And since then TOWERVIEW LLC has made 5 purchases of CRVS, at an average price of $2.22, for a total of 504,373.00 shares. In addition, there have been 3 sales at an average price of $3.79 for 376,873.00 shares. Based on historical transaction data and CRVS's current price of $3.92, TOWERVIEW LLC's estimated gain on his CRVS holdings is $809,369.29, reflecting a 72.38% gain to date.
TOWERVIEW LLC CRVS ($3.92) Holding Chart
TOWERVIEW LLC CRVS ($3.92) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
